WallStreetZenWallStreetZen

NYSEMKT: IGC
Igc Pharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Igc Pharma earnings were -$8.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest IGC earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.8M, up 6.5% from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, IGC reported annual earnings of -$13.0M, with 13% growth. The next IGC earnings date is Jun 18, 2025.

IGC earnings history

Current Revenue
$1.2M
Current Earnings
-$8.8M
Current Profit Margin
-712.7%

IGC Return on Equity

Current Company
-122.2%
Current Industry
-2%
Current Market
34.1%
IGC's Return on Equity (-122.2%)... subscribe to Premium to read more.
High Return on Equity Performance

IGC undefined

Current Company
-88.2%
Current Industry
-0.4%
IGC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IGC announces earnings.

IGC undefined

Current Company
-137.19%
Current Industry
5.9%
IGC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IGC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IGC-$8.18M-$8.81MN/A-$0.11
PULM-$9.12M-$9.56MN/A-$2.62
ENLV-$15.34M-$15.01MN/A-$0.73
CLGN-$16.21M-$16.61MN/A-$1.45
XFOR-$25.99M-$37.45MN/A-$5.70
View Top Biotech Stocks

IGC earnings dates

Next earnings date
Jun 18, 2025

Igc Pharma Earnings Reports & History FAQ

What were Igc Pharma's earnings last quarter?

On IGC's earnings call on Invalid Date, Igc Pharma (NYSEMKT: IGC) reported Q4 2024 earnings per share (EPS) of -$0.02, up 77.78% year over year. Total IGC earnings for the quarter were -$1.83 million. In the same quarter last year, Igc Pharma's earnings per share (EPS) was -$0.09.

If you're new to stock investing, here's how to buy Igc Pharma stock.

When does Igc Pharma report earnings?

The next IGC earnings date is Invalid Date. Add IGC to your watchlist to be reminded of Igc Pharma's next earnings date.

Is Igc Pharma profitable or losing money?

As of the last Igc Pharma earnings report, Igc Pharma is currently losing money. Igc Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$8.81 million, a 37.72% decrease year over year.

What was IGC's earnings growth in the past year?

As of Igc Pharma's earnings date in Invalid Date, Igc Pharma's earnings has grown year over year. IGC earnings in the past year totalled -$8.81 million.

What are Igc Pharma's earnings expectations?

The current EPS estimate for Igc Pharma's earnings report in Invalid Date is -$0.02.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.